Community/Retail

A fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was non-inferior to boosted protease inhibitor (bPI)-based regimens in virologically suppressed adults with HIV, according to a recently-published phase 3 study.

Oral vitamin D supplementation, in addition to asthma medications, could reduce the risk of asthma attacks requiring hospital attendance by 50%, according to a recently-published study in The Lancet of Respiratory Medicine.

Achieving National HIV/AIDs target goal could prevent an estimated 200,000 deaths over 20 years, according to a study recently published in the Journal of Infectious Diseases.

Vaccination offers protection from harmful diseases, such as hepatitis B, measles and pertussis, and pharmacists can counsel parents.

Social media has become a crucial tool for organizations and businesses to interact with their customers and discuss the services they offer. Many Americans look to social media for recommendations and to build stronger relationships with the brands they use.

Patients who develop chronic kidney disease (CKD) are at risk for a number of comorbidities, including cardiovascular decline.

FDA officials have approved onabotulinumtoxinA (BOTOX Cosmetic, Allergan) for its third indication for the temporary improvement in the appearance of moderate-to-severe forehead lines associated with frontalis muscle activity in adults.

According to an "FDA in Brief" report, officials with the FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV).

Most older adults don’t talk to their health care provider about sleep difficulties, even though more than one-third reported using some type of medication to help them sleep at night, according to results from the National Poll on Healthy Aging.

Each October, APhM encourages consumers to “Know Your Medicine, Know Your Pharmacist,” highlighting the important role pharmacists play as they offer assistance with prescription and over-the-counter medication choices.

There are several key therapeutics areas of which to be aware.

Committing to each part of this principle and following these guidelines will help achieve success.

Here is one pharmacist's plan to strive for more excellence professionally.

On September 29, 2017, the ASHP (American Society of Health-System Pharmacists) Board of Directors voted unanimously to approve the creation of an enhanced membership home for pharmacy technicians — the ASHP Pharmacy Technician Forum.

One barrier to treatment has been determining if the patient actually has influenza, and how long he or she has had it.

The Drug Quality and Security Act (DQSA) provides a framework for working with outsourcing facilities to meet federal regulatory standards.

Burned-out pharmacists exhibit exhaustion, chronic fatigue, alienation from work-related activities, loss of appetite, and insomnia.

This article will highlight four tips that can all pharmacists to help pay off student loans faster.

This decision was made based on a review of available phase 2 efficacy data and in consideration of the evolving marketplace and the growing number of treatment options available for patients with chronic HCV infection, including elbasvir and grazoprevir (Zepatier).

Officials with the FDA have approved fast-acting insulin aspart (Fiasp, Novo Nordisk) for the treatment of adults with diabetes.

While the FAERS dashboard now offers stakeholders many more ways of searching for and organizing data on adverse events reported to the FDA for many drug and biologic products, there remain limitations to the data.

Pertussis or whooping cough is a highly contagious respiratory disease that can be very serious and even fatal for infants younger than 1.

FDA expands approved indications for ibrutinib in August 2017.

A look at unintentional causes of injury death in the United States and medication safety.

Eliminating retroactive pharmacy payment reductions — or post point-of-sale pharmacy "DIR fees" — in Medicare Part D would save the federal government $3.4 billion over 10 years, according to a Wakely Consulting Group study released today by the National Community Pharmacists Association.

Officials with the FDA have approved abemaciclib (Verzenio, Eli Lilly), for the treatment of adults with certain advanced or metastatic breast cancer.

The agreement requires Amgen to pay royalties to AbbVie for sales of the biosimilar, according to a press release.